TradeFlare's AI research teams analysed DNLI on 5 market nights between May 7, 2026 and July 17, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| July 17, 2026 | BUY | $22.73 | $26.14 / $19.24 | -0.8% | +4.8% | The fundamental catalysts suggest a medium-term upward trend, while technicals indicate a short-term oversold bounce opportunity. |
| July 16, 2026 | BUY | $23.02 | — / — | +3.0% | +9.2% | FDA approval of AVLAYAH provides a significant commercial catalyst. |
| July 15, 2026 | BUY | $22.65 | — / — | +2.7% | +9.8% | The current technical setup is bearish despite fundamental and sentiment tailwinds, necessitating a wait-and-see approach. |
| May 8, 2026 | BUY | $19.71 | — / — | -5.1% | -0.4% | Continued positive impact from AVLAYAH™ launch and market adoption. |
| May 7, 2026 | HOLD | $20.41 | — / — | -1.6% | -1.0% | Continued positive developments from the FDA approval of Avlayah and the potential of the TransportVehicle™ platform. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.